• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

2 个月痰液涂片在预测肺结核培养转换中的作用。

Role of 2-month sputum smears in predicting culture conversion in pulmonary tuberculosis.

机构信息

Dept of Chest Medicine, Taipei Veterans General Hospital, Taipei 112, Taiwan.

出版信息

Eur Respir J. 2011 Feb;37(2):376-83. doi: 10.1183/09031936.00007410. Epub 2010 Jun 1.

DOI:10.1183/09031936.00007410
PMID:20516049
Abstract

Sputum smears and culture conversion are frequently used to evaluate treatment response in pulmonary tuberculosis patients. Limited data are available on the evaluation of the correlation between under-treatment sputum smear results and culture conversion. This prospective study included sputum culture-proven pulmonary tuberculosis patients at six hospitals in Taiwan. At least two sets of sputum were collected at the completion of 8 weeks of TB treatment. The sensitivities and specificities of 2-month sputum smears were estimated based on culture conversion status. A total of 371 patients were enrolled for analysis. Factors associated with culture conversion included having a smear positive before treatment, presence of a cavity on radiography, rifampicin resistance and usage of the DOTS (directly observed therapy, short course) strategy. The sensitivities of 2-month sputum smears for culture conversion among all patients, initially smear-positive patients and initially smear-negative patients were 64.3, 71.4 and 38%, respectively, and the specificities were 81.6, 69.9 and 92.8%, respectively. In patients who were 2-month sputum smear-positive, the 2-month culture conversion rate was 80% if the patients were under DOTS and without cavitary lesions in radiograms. The predictive value of 2-month sputum smears in culture conversion was limited and highly influenced by clinical factors in pulmonary tuberculosis patients.

摘要

痰涂片和培养转换常用于评估肺结核患者的治疗反应。关于治疗不足的痰涂片结果与培养转换之间相关性的评估,相关数据有限。本前瞻性研究纳入了台湾六家医院经痰培养证实的肺结核患者。在完成 8 周的结核病治疗后,至少收集两组痰标本。根据培养转换状态,估计 2 个月痰涂片的敏感性和特异性。共纳入 371 例患者进行分析。与培养转换相关的因素包括治疗前涂片阳性、影像学有空洞、利福平耐药和使用 DOTS(直接观察治疗、短程)策略。所有患者、初始涂片阳性患者和初始涂片阴性患者的 2 个月痰涂片对培养转换的敏感性分别为 64.3%、71.4%和 38%,特异性分别为 81.6%、69.9%和 92.8%。在 2 个月痰涂片阳性的患者中,如果患者接受 DOTS 治疗且影像学无空洞病变,则 2 个月的培养转换率为 80%。2 个月痰涂片在培养转换中的预测价值有限,并且在肺结核患者中受到临床因素的高度影响。

相似文献

1
Role of 2-month sputum smears in predicting culture conversion in pulmonary tuberculosis.2 个月痰液涂片在预测肺结核培养转换中的作用。
Eur Respir J. 2011 Feb;37(2):376-83. doi: 10.1183/09031936.00007410. Epub 2010 Jun 1.
2
Tuberculosis chemotherapy and sputum conversion among HIV-seropositive and HIV-seronegative patients in south-eastern Uganda.乌干达东南部艾滋病毒血清阳性和艾滋病毒血清阴性患者的结核病化疗与痰菌转阴情况
East Afr Med J. 1999 Jun;76(6):307-13.
3
Viable Mycobacterium tuberculosis in sputum after pulmonary tuberculosis cure.肺结核治愈后痰中仍存在存活结核分枝杆菌。
BMC Infect Dis. 2019 Oct 30;19(1):923. doi: 10.1186/s12879-019-4561-7.
4
Non conversion of sputum smears in new smear positive pulmonary tuberculosis patients in Yaoundé, Cameroon.喀麦隆雅温得新涂片阳性肺结核患者痰涂片未转阴情况
East Afr Med J. 2009 May;86(5):219-25. doi: 10.4314/eamj.v86i5.54192.
5
Factors influencing time to smear conversion in patients with smear-positive pulmonary tuberculosis.影响涂片阳性肺结核患者涂片转阴时间的因素。
Respirology. 2009 Sep;14(7):1012-9. doi: 10.1111/j.1440-1843.2009.01598.x. Epub 2009 Jul 30.
6
Relative versus absolute noncontagiousness of respiratory tuberculosis on treatment.呼吸道结核在治疗中的相对与绝对非传染性
Infect Control Hosp Epidemiol. 2003 Nov;24(11):831-8. doi: 10.1086/502145.
7
Outcome correlation of smear-positivity for acid-fast bacilli at the fifth month of treatment in non-multidrug-resistant TB.非耐多药结核病治疗第 5 个月时痰涂片抗酸杆菌阳性的结果相关性。
Chest. 2013 Jun;143(6):1725-1732. doi: 10.1378/chest.12-2051.
8
Time to sputum conversion in smear positive pulmonary TB patients on category I DOTS and factors delaying it.采用直接观察治疗短程化疗(DOTS)方案I治疗的涂片阳性肺结核患者的痰菌转阴时间及其延迟因素。
J Assoc Physicians India. 2012 Aug;60:22-6.
9
[In 76% of patients with active tuberculosis treated with triple therapy (isoniazid-rifampicin-pyrazinamide) cultural conversion precedes microscopic conversion].在接受三联疗法(异烟肼-利福平-吡嗪酰胺)治疗的活动性肺结核患者中,76%的患者培养转阴先于显微镜检查转阴。
Pneumologie. 1990 Feb;44 Suppl 1:497-8.
10
Characteristics and outcome of tuberculosis patients whose sputum smears are positive at or after 5 months of treatment.治疗5个月及以后痰涂片仍呈阳性的肺结核患者的特征及转归
Int J Tuberc Lung Dis. 2004 Mar;8(3):384-7.

引用本文的文献

1
Shifting sands: Unveiling the changes in respiratory comorbidities and fungal pathogens in Saudi Arabia.变幻莫测:揭示沙特阿拉伯呼吸道合并症和真菌病原体的变化
Saudi Med J. 2025 Feb;46(2):182-189. doi: 10.15537/smj.2025.46.2.20240616.
2
Optimized anti-tuberculosis duration for drug-susceptible pulmonary tuberculosis-diabetes mellitus comorbidities: study protocol for a multicenter randomized controlled trial.优化耐多药肺结核合并糖尿病患者的抗结核疗程:一项多中心随机对照试验研究方案。
BMC Pulm Med. 2024 Sep 27;24(1):469. doi: 10.1186/s12890-024-03271-8.
3
Early Microbiologic Markers of Pulmonary Tuberculosis Treatment Outcomes.
早期微生物学标志物与肺结核治疗结局。
Ann Am Thorac Soc. 2023 Dec;20(12):1760-1768. doi: 10.1513/AnnalsATS.202302-144OC.
4
TB therapeutic drug monitoring - analysis of opportunities in Romania and Ukraine.结核病治疗药物监测——罗马尼亚和乌克兰的机遇分析。
Int J Tuberc Lung Dis. 2023 Nov 1;27(11):816-821. doi: 10.5588/ijtld.22.0667.
5
Prolongation of Acid-Fast Bacilli Sputum Smear Positivity in Patients with Multidrug-Resistant Pulmonary Tuberculosis.耐多药肺结核患者痰涂片抗酸杆菌阳性持续时间延长
Pathogens. 2023 Sep 5;12(9):1133. doi: 10.3390/pathogens12091133.
6
Time to Sputum Culture Conversion and Its Predictors Among Multidrug Resistant Tuberculosis Patients in Tigray, Northern Ethiopia: Retrospective Cohort Study.埃塞俄比亚北部提格雷地区耐多药结核病患者痰培养转阴时间及其预测因素:回顾性队列研究
Infect Drug Resist. 2023 Jun 9;16:3671-3681. doi: 10.2147/IDR.S413495. eCollection 2023.
7
Time to sputum conversion in patients with pulmonary tuberculosis: A score to estimate the infectious period.肺结核患者痰菌转阴时间:一种评估传染期的评分方法。
J Clin Tuberc Other Mycobact Dis. 2023 Mar 16;31:100361. doi: 10.1016/j.jctube.2023.100361. eCollection 2023 May.
8
Circulating mitochondrial cell-free DNA dynamics in patients with mycobacterial pulmonary infections: Potential for a novel biomarker of disease.循环线粒体细胞游离 DNA 动力学在分枝杆菌肺部感染患者中的变化:疾病新型生物标志物的潜在可能。
Front Immunol. 2022 Nov 15;13:1040947. doi: 10.3389/fimmu.2022.1040947. eCollection 2022.
9
High Pretreatment Level of Neutrophil to Lymphocyte Ratio, Monocyte to Lymphocyte Ratio and Other Factors Associated with Delayed Sputum Conversion in Patients with Pulmonary Tuberculosis.肺结核患者治疗前中性粒细胞与淋巴细胞比值、单核细胞与淋巴细胞比值及其他因素与痰菌转阴延迟相关。
Infect Drug Resist. 2022 Sep 15;15:5455-5462. doi: 10.2147/IDR.S380166. eCollection 2022.
10
Screening performance of C-reactive protein for active pulmonary tuberculosis in HIV-positive patients: A systematic review with a meta-analysis.C 反应蛋白在 HIV 阳性患者活动性肺结核中的筛查效能:一项系统评价与荟萃分析。
Front Immunol. 2022 Aug 25;13:891201. doi: 10.3389/fimmu.2022.891201. eCollection 2022.